(Q43718996)

26 November 2017

Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

26 October 2022

main subject

multiple drug resistance

1 reference

1

A. F. List

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1675116

26 October 2022

author name string

C. M. Spier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1675116

26 October 2022

A. Cline

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1675116

26 October 2022

D. C. Doll

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1675116

26 October 2022

H. Garewal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1675116

26 October 2022

R. Morgan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1675116

26 October 2022

A. A. Sandberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1675116

26 October 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

full work available at URL

26 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.1991.tb04378.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1991.tb04378.x/fullpdf

26 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

British Journal of Haematology

26 October 2022

published in

1 reference

26 November 2017

78

1 reference

26 November 2017

28-34

1 reference

26 November 2017

1

1 reference

Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics.

26 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Localization of the human multiple drug resistance gene, MDR1, to 7q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Multidrug resistance: molecular biology and clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB04378.X

An international system for human cytogenetic nomenclature (1978) ISCN (1978). Report of the Standing Commitee on Human Cytogenetic Nomenclature

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

Proceedings of the American Association for Cancer Research

26 October 2022

3

30

504a

Bhushan A.

1989

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

26 October 2022

4

14

372

Bloomfield C.D.

1987

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

Leukemia risk following radiotherapy for breast cancer

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

Expression of a multidrug resistance gene in human cancers

26 October 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia.

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

Proceedings of the American Association for Cancer Research

26 October 2022

25

30

501a

Kadoyama C.

1989

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

26 October 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines

26 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival

26 October 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

Immunophenotypes in "well-differentiated" lymphoproliferative disorders, with emphasis on small lymphocytic lymphoma

26 October 2022

40

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB04378.X

26 October 2022

Identifiers

1 reference

26 November 2017

1 reference